Christopher Morabito, MD
May 7, 2021
Chris Morabito, MD has extensive leadership experience at biotechnology and pharmaceutical companies and has advanced discovery and clinical programs including Phase 1, proof-of-concept and pivotal studies. Most recently, he served as chief medical officer at Cardurion Pharmaceuticals where he oversaw all drug development activities. Prior to Cardurion, he served in several roles at Takeda, including program leadership and head of pipeline strategy, most recently serving as senior vice president and head of research and development for plasma-derived protein therapies. He also led programs from early development stage through regulatory submission at Sanofi and he began his career in industry at Merck & Co, leading development of multiple cardiovascular assets. Chris was also chief of the division of neonatology at Lehigh Valley Hospital and Health Network. He trained initially as a neonatologist at the University of California, San Francisco. He earned his B.A. in biology from Franklin and Marshall College, and his M.D. from Penn State University College of Medicine.